BlossomHill Therapeutics, Inc. Ttl Offset Amt
BlossomHill Therapeutics, Inc. (BLSM) had Ttl Offset Amt of $0 as of 2026-08-07, per its S-8 filed 2026-08-10.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-08-10
- 2026-08-07: Ttl Offset Amt $0.00.
- 2026-08-06: Ttl Offset Amt $0.00.
- 2026-07-30: Ttl Offset Amt $0.00.
- 2026-07-10: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-08-07 | $0.00 S-8 · filed 2026-08-10 |
| 2026-08-06 | $0.00 S-1MEF · filed 2026-08-06 |
| 2026-07-30 | $0.00 S-1/A · filed 2026-08-03 |
| 2026-07-10 | $0.00 S-1 · filed 2026-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |